Corient Capital Partners’s Clorox CLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
– Sell
-1,455
Closed -$254K – 749
2021
Q4
$254K Sell
1,455
-130
-8% -$21.7K 0.02% 583
2021
Q3
$262K Buy
1,585
+67
+4% +$11.5K 0.02% 536
2021
Q2
$273K Buy
1,518
+75
+5% +$13.7K 0.02% 510
2021
Q1
$278K Buy
1,443
+82
+6% +$15.8K 0.02% 465
2020
Q4
$275K Buy
1,361
+118
+9% +$24.4K 0.03% 405
2020
Q3
$261K Sell
1,243
-19
-2% -$4.23K 0.03% 370
2020
Q2
$277K Buy
+1,262
New +$252K 0.03% 353

Other funds holding CLX

Corient Capital Partners's CLX Position: Q1 2022 in Review

Corient Capital Partners sold out of Clorox (CLX) in Q1 2022, closing a stake of 1,455 shares — an estimated $254K sold.

Corient Capital Partners first reported a position in CLX in Q2 2020 and held it in 7 quarters. The position peaked at $278K in Q1 2021. 1,093 funds tracked by Wall St. Rank hold CLX as of Q1 2022.

  • Corient Capital Partners reported no remaining Clorox position as of Q1 2022 after selling out during the quarter.
  • Corient Capital Partners sold 1,455 Clorox shares in Q1 2022, an estimated $254K.
  • Corient Capital Partners first reported a position in Clorox in Q2 2020 and held it in 7 quarters.
  • Corient Capital Partners's Clorox position peaked at $278K in Q1 2021.
  • 1,093 funds tracked by Wall St. Rank held Clorox as of Q1 2022.

Based on Corient Capital Partners's 13F filing for Q1 2022, filed 16 May 2022.